Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs Mirabegron

    Virtual Booth

    Contact Supplier

    Mirabegron

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem Mirabegron

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mirabegron

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,730Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Betanis/Myrbetriq/Beiga

    02 7Betanis/Myrbetriq/Betmiga

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Betanis/Myrbetriq/Betmiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Betmiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas

    Mirabegron

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2020 Revenue in Millions : 1,492

    2019 Revenue in Millions : 1,451

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Betanis/Myrbetriq/Betmiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Betmiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas

    Mirabegron

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2021 Revenue in Millions : 1,420

    2020 Revenue in Millions : 1,481

    Growth (%) : 3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Betanis/Myrbetriq/Betmiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Betmiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas

    Mirabegron

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2022 Revenue in Millions : 1,437

    2021 Revenue in Millions : 1,455

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Betanis/Myrbetriq/Betmiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Betmiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas

    Mirabegron

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2023 Revenue in Millions : 1,284

    2022 Revenue in Millions : 1,437

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Betanis/Myrbetriq/Betmiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Betmiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas

    Mirabegron

    Main Therapeutic Indication : Renal Disorders

    Currency : USD

    2018 Revenue in Millions : 1,287

    2017 Revenue in Millions : 1,003

    Growth (%) : 28%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Betanis/Myrbetriq/Betmiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Betmiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas

    Mirabegron

    Main Therapeutic Indication : Renal Disorders

    Currency : USD

    2016 Revenue in Millions : 839

    2015 Revenue in Millions : 679

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Betanis/Myrbetriq/Beiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Beiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas Pharma

    Mirabegron

    Main Therapeutic Indication : Renal Disorders

    Currency : USD

    2017 Revenue in Millions : 1,070

    2016 Revenue in Millions : 895

    Growth (%) : 20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Betanis/Myrbetriq/Betmiga

    Mirabegron

    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Brand Name : Betanis/Myrbetriq/Betmiga

    Japan
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    Astellas

    Mirabegron

    Main Therapeutic Indication : Nephrology

    Currency : USD

    2019 Revenue in Millions : 1,472

    2018 Revenue in Millions : 1,325

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF